IL101599A - 3-) Pyridinylamino (-indulates converted to benzo [B] theophanes, a method for their preparation and a pharmaceutical preparation containing them - Google Patents

3-) Pyridinylamino (-indulates converted to benzo [B] theophanes, a method for their preparation and a pharmaceutical preparation containing them

Info

Publication number
IL101599A
IL101599A IL10159992A IL10159992A IL101599A IL 101599 A IL101599 A IL 101599A IL 10159992 A IL10159992 A IL 10159992A IL 10159992 A IL10159992 A IL 10159992A IL 101599 A IL101599 A IL 101599A
Authority
IL
Israel
Prior art keywords
compound
formula
loweralkyl
hydrogen
afford
Prior art date
Application number
IL10159992A
Other languages
English (en)
Hebrew (he)
Other versions
IL101599A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL101599A0 publication Critical patent/IL101599A0/xx
Publication of IL101599A publication Critical patent/IL101599A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL10159992A 1991-04-17 1992-04-15 3-) Pyridinylamino (-indulates converted to benzo [B] theophanes, a method for their preparation and a pharmaceutical preparation containing them IL101599A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/688,964 US5177088A (en) 1991-04-17 1991-04-17 Substituted 3-(pyridinylamino)-indoles

Publications (2)

Publication Number Publication Date
IL101599A0 IL101599A0 (en) 1992-12-30
IL101599A true IL101599A (en) 1996-05-14

Family

ID=24766519

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10159992A IL101599A (en) 1991-04-17 1992-04-15 3-) Pyridinylamino (-indulates converted to benzo [B] theophanes, a method for their preparation and a pharmaceutical preparation containing them

Country Status (25)

Country Link
US (1) US5177088A (fi)
EP (1) EP0509402B1 (fi)
JP (1) JP2617650B2 (fi)
KR (1) KR100254027B1 (fi)
AT (1) ATE161840T1 (fi)
AU (1) AU655253B2 (fi)
BG (1) BG61034B1 (fi)
CA (1) CA2066332C (fi)
CS (1) CS117192A3 (fi)
DE (1) DE69223837T2 (fi)
DK (1) DK0509402T3 (fi)
ES (1) ES2111580T3 (fi)
FI (1) FI105096B (fi)
GR (1) GR3026317T3 (fi)
HU (1) HU215113B (fi)
IE (1) IE921235A1 (fi)
IL (1) IL101599A (fi)
MX (1) MX9201759A (fi)
NO (1) NO180486C (fi)
NZ (1) NZ242359A (fi)
PL (1) PL168905B1 (fi)
RO (1) RO109847B1 (fi)
RU (1) RU2060254C1 (fi)
TW (1) TW200477B (fi)
ZA (1) ZA922807B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
HUP9802492A3 (en) * 1995-06-06 1999-10-28 Hoechst Marion Roussel Inc Cin Benzisoxazole and indazole derivatives as antipsychotic agents, process for their preparation and pharmaceutical compositions containing the same
US5668154A (en) * 1995-06-06 1997-09-16 Hoechst Marion Roussel Inc. Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
DK0950056T3 (da) * 1996-12-27 2003-01-27 Aventis Pharma Inc N-(pyridinylamino)isoindoliner og beslægtede forbindelser
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
PT1216244E (pt) * 1999-09-14 2003-12-31 Aventis Pharma Inc Derivados de benzisoxazolil- piridoisoxazolil- e benztienil-fenoxi uteis como antagonistas d4
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
DE10029371A1 (de) 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
GB0217920D0 (en) * 2002-04-23 2002-09-11 Aventis Pharm Prod Inc Interleukin-4 Gene Expression inhibitors
ATE462692T1 (de) 2004-06-01 2010-04-15 Hoffmann La Roche 3-amino-1-arylpropyl-indole als monoamin- wiederaufnahmehemmer
BRPI0619263A2 (pt) 2005-11-30 2011-09-27 Hoffmann La Roche indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis
WO2007062998A1 (en) 2005-11-30 2007-06-07 F. Hoffmann-La Roche Ag 3-amino-2-arylpropyl azaindoles and uses thereof
EP2351737A1 (en) * 2005-11-30 2011-08-03 F. Hoffmann-La Roche AG 3-Amino-1-arylpropyl indoles and aza-substituted indoles
US20100291533A1 (en) * 2008-01-04 2010-11-18 Soon Ha Kim Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049779B1 (en) * 1980-09-18 1984-10-31 Asahi Kasei Kogyo Kabushiki Kaisha 3-aminoindazole derivatives and process for preparation thereof
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4717658A (en) * 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives

Also Published As

Publication number Publication date
NO180486C (no) 1997-04-30
US5177088A (en) 1993-01-05
IE921235A1 (en) 1992-10-21
PL294239A1 (en) 1993-06-14
RO109847B1 (ro) 1995-06-30
ES2111580T3 (es) 1998-03-16
RU2060254C1 (ru) 1996-05-20
DE69223837D1 (de) 1998-02-12
JP2617650B2 (ja) 1997-06-04
HUT62572A (en) 1993-05-28
GR3026317T3 (en) 1998-06-30
DK0509402T3 (da) 1998-09-07
FI105096B (fi) 2000-06-15
FI921693A0 (fi) 1992-04-15
KR100254027B1 (ko) 2000-05-01
PL168905B1 (pl) 1996-05-31
HU215113B (hu) 1998-12-28
CS117192A3 (en) 1992-11-18
JPH05117266A (ja) 1993-05-14
DE69223837T2 (de) 1998-06-25
CA2066332C (en) 2003-07-29
BG96202A (bg) 1993-12-24
NO921505D0 (no) 1992-04-15
HU9201297D0 (en) 1992-07-28
MX9201759A (es) 1992-10-01
CA2066332A1 (en) 1992-10-18
FI921693A (fi) 1992-10-18
NZ242359A (en) 1995-03-28
AU655253B2 (en) 1994-12-08
NO180486B (no) 1997-01-20
EP0509402A1 (en) 1992-10-21
ZA922807B (en) 1992-11-25
TW200477B (fi) 1993-02-21
IL101599A0 (en) 1992-12-30
KR920019777A (ko) 1992-11-20
NO921505L (no) 1992-10-19
ATE161840T1 (de) 1998-01-15
AU1512192A (en) 1992-10-22
BG61034B1 (bg) 1996-09-30
EP0509402B1 (en) 1998-01-07

Similar Documents

Publication Publication Date Title
EP0509402B1 (en) Substituted 3-(Pyridinylamino)-indoles and benzo[b]thiophenes, a process for their preparation and their use as medicaments
RU2449990C2 (ru) Индолы в качестве модуляторов 5-ht6
JP5165568B2 (ja) ５−ＨＴ２Ｃ受容体アゴニストとしての６−置換−２，３，４，５−テトラヒドロ−１Ｈ−ベンゾ［ｄ］アゼピン
CZ284371B6 (cs) Nové (R)-5-karbamoyl-8-fluor-3-N,N-disubstituované amino-3,4-dihydro-2H-1-benzopyrany
AU2003259158A1 (en) 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
EP0694033A1 (en) Indole derivatives as 5-ht1a and/or 5-ht2 ligands
KR101107807B1 (ko) 5-ｈｔ(5ａ) 수용체 길항제로서의 2-아미노퀴놀린
TW200911253A (en) Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
US5328920A (en) Substituted (pyridinylamino)-indoles
EP1749001B1 (en) 3-piperidinylisochroman-5-ols as dopamine agonists
JP2003521443A (ja) ４，５，６及び７−インドール及びインドリン誘導体、その製造方法及びその使用方法
JP2002536291A (ja) ２−（４−アリール又はヘテロアリール−ピペラジン−１−イルメチル）−１ｈ−インドール誘導体
KR100292212B1 (ko) 치환된아미노티에노피리딘,이의제조방법및이를포함하는약제학적조성물
CA2078814C (en) Substituted pyridinylamino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo[b]thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments
JP2003517481A (ja) 抗精神病複素環式化合物
AU2004289656A1 (en) Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-Hydroxytryptamine-6 ligands
EP1366044B1 (en) 8-{4-[3-(5-fluoro-1h-indol-3-yl)propyl ]-1-piperazinyl} -2-methyl-2h-1, 4-benzoxazin-3(4h)-one methanesulfonate with high affinity for the dopamine d2 receptor and the serotonin reuptake site
US6022880A (en) Substituted pyridylamino indoles
CN112041300A (zh) 作为双重5-ht2a和5-ht6受体拮抗剂的吲哚和苯并咪唑衍生物
JP2009545555A (ja) 置換インダニルスルホンアミド化合物、それらの調製、および薬剤としての使用
JP2002088084A (ja) ジアザビシクロオクタン誘導体およびそれらの治療的使用
US20040198734A1 (en) 2-(4-Aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine
CA2327513A1 (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression
MXPA00009808A (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees